Advocacy Brief on Breastfeeding and HIV

Led by UNICEF and WHO, the Global Breastfeeding Collective is a partnership of more than 20 prominent international agencies calling on donors, policymakers, philanthropists and civil society to increase investment in breastfeeding worldwide. The Collective’s vision is a world in which all mothers have the technical, financial, emotional and public support they need to breastfeed. The Collective advocates for smart investments in breastfeeding programmes, assists policymakers and NGOs in implementing solutions, and galvanizes support to get real results to increase rates of breastfeeding, thereby benefiting mothers, children and nations.

Download the advocacy brief on breastfeeding and HIV above. Learn more at unicef.org/breastfeeding.

 

WHO Policy Brief: 2018 optimal formulary and limited-use list for paediatric ARVs

The WHO 2018 guideline update promotes the use of optimal treatment regimens in all populations. Though new, more effective and better tolerated options with a higher genetic barrier to resistance are now available for adults, optimized treatment options for children lag significantly behind.

This fifth edition of the Optimal Formulary and Limited-use List supports the transition to optimal WHO-recommended regimens for infants and children, while giving due consideration to the rapidly evolving treatment landscape and the risks inherent in the uncertain timelines for paediatric drug development.

HIV and infant feeding in emergencies: operational guidance (2018)

Many millions of people around the world are affected by emergencies, the majority of whom are women and children. Among them are many who are known to be living with HIV and others who may not know their HIV status.

The purpose of this document is to provide operational guidance on HIV and infant feeding in emergencies. It is intended to be used to complement emergency and sectoral guidelines on health, nutrition and HIV, including specifically infant feeding, prevention of mother-to-child transmission of HIV and paediatric antiretroviral treatment.

The envisaged target audience consists of decision makers, policymakers, national and subnational government managers and planners, managers of refugee camps and similar settlements for displaced persons, and managers and planners in United Nations agencies, nongovernmental organizations and other groups responding to humanitarian situations.

This operational guidance is based on a consultation convened by the WHO, UNICEF and the Emergency Nutrition Network in Geneva in September 2016, which brought together a cross-section of senior-level participants from United Nations agencies, government, nongovernmental organizations, academia, and other agencies working in nutrition and HIV in emergencies. This document sets out basic principles related to HIV and infant feeding in emergency settings, and the actions that government and other stakeholders can take to prepare for emergencies.

Cuba Validation: Next Steps, WHO (2015)

In July 2015, the IATT hosted a webinar with WHO, PAHO and the Ministry of Health of Cuba to discuss the validation process for the dual elimination of MTCT of HIV and syphilis. A total of 68 participants joined the webinar from a range of countries including China, Ethiopia, DRC, Namibia and Nigeria. Additional downloads of the webinar presentations, virtual discussion summary and Q&A transcript can be found here: Cuba Validation on EMTCT of HIV & Syphilis (Jul 2015).

Cuba Validation: EMTCT of HIV and Congenital Syphilis, MOH Cuba (2015)

In July 2015, the IATT hosted a webinar with WHO, PAHO and the Ministry of Health of Cuba to discuss the validation process for the dual elimination of MTCT of HIV and syphilis. A total of 68 participants joined the webinar from a range of countries including China, Ethiopia, DRC, Namibia and Nigeria. Additional downloads of the webinar presentations, virtual discussion summary and Q&A transcript can be found here: Cuba Validation on EMTCT of HIV & Syphilis (Jul 2015).

Cuba Validation: Linkages to the Global Plan, UNAIDS (2015)

In July 2015, the IATT hosted a webinar with WHO, PAHO and the Ministry of Health of Cuba to discuss the validation process for the dual elimination of MTCT of HIV and syphilis. A total of 68 participants joined the webinar from a range of countries including China, Ethiopia, DRC, Namibia and Nigeria. Additional downloads of the webinar presentations, virtual discussion summary and Q&A transcript can be found here: Cuba Validation on EMTCT of HIV & Syphilis (Jul 2015).

Cuba Validation: IATT Webinar Summary and Q&A Transcript, (2015)

In July 2015, the IATT hosted a webinar with WHO, PAHO and the Ministry of Health of Cuba to discuss the validation process for the dual elimination of MTCT of HIV and syphilis. A total of 68 participants joined the webinar from a range of countries including China, Ethiopia, DRC, Namibia and Nigeria. Additional downloads of the webinar presentations, virtual discussion summary and Q&A transcript can be found here: Cuba Validation on EMTCT of HIV & Syphilis (Jul 2015).

Cuba Validation: IATT Virtual Discussion Summary, (2015)

In July 2015, the IATT hosted a webinar with WHO, PAHO and the Ministry of Health of Cuba to discuss the validation process for the dual elimination of MTCT of HIV and syphilis. A total of 68 participants joined the webinar from a range of countries including China, Ethiopia, DRC, Namibia and Nigeria. Additional downloads of the webinar presentations, virtual discussion summary and Q&A transcript can be found here: Cuba Validation on EMTCT of HIV & Syphilis (Jul 2015).

Cuba Validation: EMTCT of HIV and Congenital Syphilis in the Americas, PAHO (2015)

In July 2015, the IATT hosted a webinar with WHO, PAHO and the Ministry of Health of Cuba to discuss the validation process for the dual elimination of MTCT of HIV and syphilis. A total of 68 participants joined the webinar from a range of countries including China, Ethiopia, DRC, Namibia and Nigeria. Additional downloads of the webinar presentations, virtual discussion summary and Q&A transcript can be found here: Cuba Validation on EMTCT of HIV & Syphilis (Jul 2015).